Danaher Co. (NYSE:DHR) Shares Purchased by Treasurer of the State of North Carolina

Treasurer of the State of North Carolina lifted its position in Danaher Co. (NYSE:DHR) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 338,636 shares of the conglomerate’s stock after acquiring an additional 3,038 shares during the period. Treasurer of the State of North Carolina’s holdings in Danaher were worth $77,734,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Howard Capital Management Group LLC grew its holdings in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 48 shares during the last quarter. Coldstream Capital Management Inc. grew its holdings in shares of Danaher by 6.7% during the third quarter. Coldstream Capital Management Inc. now owns 16,318 shares of the conglomerate’s stock worth $4,512,000 after purchasing an additional 1,019 shares during the last quarter. TD Private Client Wealth LLC raised its position in Danaher by 1.0% in the 3rd quarter. TD Private Client Wealth LLC now owns 17,946 shares of the conglomerate’s stock worth $4,989,000 after purchasing an additional 169 shares during the last quarter. Soltis Investment Advisors LLC grew its position in shares of Danaher by 19.3% during the 3rd quarter. Soltis Investment Advisors LLC now owns 1,563 shares of the conglomerate’s stock worth $434,000 after buying an additional 253 shares during the period. Finally, Discipline Wealth Solutions LLC acquired a new position in Danaher in the third quarter valued at about $314,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 10.0 %

Shares of Danaher stock opened at $192.18 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a fifty day moving average of $204.91 and a 200 day moving average of $231.11. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a market capitalization of $137.35 billion, a P/E ratio of 36.40, a P/E/G ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business posted $2.09 EPS. On average, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 24.24%.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research note on Friday, December 13th. Wells Fargo & Company reduced their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Guggenheim began coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Finally, Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $278.24.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.